Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYHZ2300178	尼洛替尼胶囊	nilotinib	Capsule	Chemical Drugs	License Renew	2023-04-11					view
JYHZ2300177	尼洛替尼胶囊	nilotinib	Capsule	Chemical Drugs	License Renew	2023-04-11					view
JYHZ2200023	尼洛替尼胶囊	nilotinib	Capsule	Chemical Drugs	License Renew	2022-01-21					view
JYHZ1800392	尼洛替尼胶囊	nilotinib	Capsule	Chemical Drugs	License Renew	2018-11-16	Novartis Pharma Schweiz AG	Novartis Pharma Schweiz AG	Certificate Issued	2019-01-29	view
JYHZ1700033	尼洛替尼胶囊	nilotinib	Capsule	Chemical Drugs	License Renew	2017-08-03	Novartis Pharma Schweiz AG	Novartis Pharma Schweiz AG	Certificate Issued	2017-10-19	view
JYHS2300114	尼洛替尼胶囊	nilotinib	Capsule	Chemical Drugs(5.2)	Import Drug Application	2023-09-06		Msn Laboratories Private Ltd			view
JYHS2300113	尼洛替尼胶囊	nilotinib	Capsule	Chemical Drugs(5.2)	Import Drug Application	2023-09-06		Msn Laboratories Private Ltd			view
JYHS2300084	尼洛替尼胶囊	nilotinib	Capsule	Chemical Drugs(5.2)	Import Drug Application	2023-07-06					view
JYHS2300083	尼洛替尼胶囊	nilotinib	Capsule	Chemical Drugs(5.2)	Import Drug Application	2023-07-06					view
JYHB2001445	尼洛替尼胶囊	nilotinib	Capsule	Chemical Drugs	Supplementary Application	2020-08-21	Novartis Pharma Schweiz AG	Novartis Pharma Schweiz AG	Certificate Issued	2020-11-03	view
JYHB2001444	尼洛替尼胶囊	nilotinib	Capsule	Chemical Drugs	Supplementary Application	2020-08-21	Novartis Pharma Schweiz AG	Novartis Pharma Schweiz AG	Certificate Issued	2020-11-03	view
JYHB2001443	尼洛替尼胶囊	nilotinib	Capsule	Chemical Drugs	Supplementary Application	2020-08-21	Novartis Pharma Schweiz AG	Novartis Pharma Schweiz AG	Certificate Issued	2020-11-03	view
JYHB2000838	尼洛替尼胶囊	nilotinib	Capsule	Chemical Drugs	Supplementary Application	2020-06-15	Novartis Pharma Schweiz AG	Novartis Pharma Schweiz AG	Filed	2020-06-19	view
JYHB2000837	尼洛替尼胶囊	nilotinib	Capsule	Chemical Drugs	Supplementary Application	2020-06-15	Novartis Pharma Schweiz AG	Novartis Pharma Schweiz AG	Filed	2020-06-19	view
JYHB2000836	尼洛替尼胶囊	nilotinib	Capsule	Chemical Drugs	Supplementary Application	2020-06-15	Novartis Pharma Schweiz AG	Novartis Pharma Schweiz AG	Filed	2020-06-19	view
JYHB2000361	尼洛替尼胶囊	nilotinib	Capsule	Chemical Drugs	Supplementary Application	2020-04-01	Novartis Pharma Schweiz AG	Novartis Pharma Schweiz AG	Filed	2020-04-13	view
JYHB2000360	尼洛替尼胶囊	nilotinib	Capsule	Chemical Drugs	Supplementary Application	2020-04-01	Novartis Pharma Schweiz AG	Novartis Pharma Schweiz AG	Filed	2020-04-13	view
JYHB2000359	尼洛替尼胶囊	nilotinib	Capsule	Chemical Drugs	Supplementary Application	2020-04-01	Novartis Pharma Schweiz AG	Novartis Pharma Schweiz AG	Filed	2020-04-13	view
JYHB1801412	尼洛替尼胶囊	nilotinib	Capsule	Chemical Drugs	Supplementary Application	2018-12-14	Novartis Pharma Schweiz AG	Novartis Pharma Schweiz AG	Certificate Issued	2019-11-18	view
JYHB1801411	尼洛替尼胶囊	nilotinib	Capsule	Chemical Drugs	Supplementary Application	2018-12-14	Novartis Pharma Schweiz AG	Novartis Pharma Schweiz AG	Certificate Issued	2019-11-18	view